Table of Contents
2019-2024 Global Therapeutic Radioisotopes Consumption Market Report
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Therapeutic Radioisotopes Consumption 2014-2024
2.1.2 Therapeutic Radioisotopes Consumption CAGR by Region
2.2 Therapeutic Radioisotopes Segment by Type
2.2.1 Radium-223
2.2.2 Lutetium-177
2.2.3 Iodine-131
2.2.4 Other
2.3 Therapeutic Radioisotopes Consumption by Type
2.3.1 Global Therapeutic Radioisotopes Consumption Market Share by Type (2014-2019)
2.3.2 Global Therapeutic Radioisotopes Revenue and Market Share by Type (2014-2019)
2.3.3 Global Therapeutic Radioisotopes Sale Price by Type (2014-2019)
2.4 Therapeutic Radioisotopes Segment by Application
2.4.1 Thyroid
2.4.2 Bone Metastasis
2.4.3 Lymphoma
2.4.4 Other
2.5 Therapeutic Radioisotopes Consumption by Application
2.5.1 Global Therapeutic Radioisotopes Consumption Market Share by Application (2014-2019)
2.5.2 Global Therapeutic Radioisotopes Value and Market Share by Application (2014-2019)
2.5.3 Global Therapeutic Radioisotopes Sale Price by Application (2014-2019)
3 Global Therapeutic Radioisotopes by Players
3.1 Global Therapeutic Radioisotopes Sales Market Share by Players
3.1.1 Global Therapeutic Radioisotopes Sales by Players (2017-2019)
3.1.2 Global Therapeutic Radioisotopes Sales Market Share by Players (2017-2019)
3.2 Global Therapeutic Radioisotopes Revenue Market Share by Players
3.2.1 Global Therapeutic Radioisotopes Revenue by Players (2017-2019)
3.2.2 Global Therapeutic Radioisotopes Revenue Market Share by Players (2017-2019)
3.3 Global Therapeutic Radioisotopes Sale Price by Players
3.4 Global Therapeutic Radioisotopes Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Therapeutic Radioisotopes Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Therapeutic Radioisotopes Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Therapeutic Radioisotopes by Regions
4.1 Therapeutic Radioisotopes by Regions
4.1.1 Global Therapeutic Radioisotopes Consumption by Regions
4.1.2 Global Therapeutic Radioisotopes Value by Regions
4.2 Americas Therapeutic Radioisotopes Consumption Growth
4.3 APAC Therapeutic Radioisotopes Consumption Growth
4.4 Europe Therapeutic Radioisotopes Consumption Growth
4.5 Middle East & Africa Therapeutic Radioisotopes Consumption Growth
5 Americas
5.1 Americas Therapeutic Radioisotopes Consumption by Countries
5.1.1 Americas Therapeutic Radioisotopes Consumption by Countries (2014-2019)
5.1.2 Americas Therapeutic Radioisotopes Value by Countries (2014-2019)
5.2 Americas Therapeutic Radioisotopes Consumption by Type
5.3 Americas Therapeutic Radioisotopes Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Therapeutic Radioisotopes Consumption by Countries
6.1.1 APAC Therapeutic Radioisotopes Consumption by Countries (2014-2019)
6.1.2 APAC Therapeutic Radioisotopes Value by Countries (2014-2019)
6.2 APAC Therapeutic Radioisotopes Consumption by Type
6.3 APAC Therapeutic Radioisotopes Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Therapeutic Radioisotopes by Countries
7.1.1 Europe Therapeutic Radioisotopes Consumption by Countries (2014-2019)
7.1.2 Europe Therapeutic Radioisotopes Value by Countries (2014-2019)
7.2 Europe Therapeutic Radioisotopes Consumption by Type
7.3 Europe Therapeutic Radioisotopes Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Therapeutic Radioisotopes by Countries
8.1.1 Middle East & Africa Therapeutic Radioisotopes Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Therapeutic Radioisotopes Value by Countries (2014-2019)
8.2 Middle East & Africa Therapeutic Radioisotopes Consumption by Type
8.3 Middle East & Africa Therapeutic Radioisotopes Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Therapeutic Radioisotopes Distributors
10.3 Therapeutic Radioisotopes Customer
11 Global Therapeutic Radioisotopes Market Forecast
11.1 Global Therapeutic Radioisotopes Consumption Forecast (2019-2024)
11.2 Global Therapeutic Radioisotopes Forecast by Regions
11.2.1 Global Therapeutic Radioisotopes Forecast by Regions (2019-2024)
11.2.2 Global Therapeutic Radioisotopes Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Therapeutic Radioisotopes Forecast by Type
11.8 Global Therapeutic Radioisotopes Forecast by Application
12 Key Players Analysis
12.1 Bayer
12.1.1 Company Details
12.1.2 Therapeutic Radioisotopes Product Offered
12.1.3 Bayer Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Bayer News
12.2 Novartis
12.2.1 Company Details
12.2.2 Therapeutic Radioisotopes Product Offered
12.2.3 Novartis Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Novartis News
12.3 China Isotope & Radiation
12.3.1 Company Details
12.3.2 Therapeutic Radioisotopes Product Offered
12.3.3 China Isotope & Radiation Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 China Isotope & Radiation News
12.4 Dongcheng
12.4.1 Company Details
12.4.2 Therapeutic Radioisotopes Product Offered
12.4.3 Dongcheng Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Dongcheng News
12.5 Q BioMed
12.5.1 Company Details
12.5.2 Therapeutic Radioisotopes Product Offered
12.5.3 Q BioMed Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Q BioMed News
12.6 Curium Pharmaceuticals
12.6.1 Company Details
12.6.2 Therapeutic Radioisotopes Product Offered
12.6.3 Curium Pharmaceuticals Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Curium Pharmaceuticals News
12.7 Jubilant DraxImage
12.7.1 Company Details
12.7.2 Therapeutic Radioisotopes Product Offered
12.7.3 Jubilant DraxImage Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 Jubilant DraxImage News
12.8 Lantheus
12.8.1 Company Details
12.8.2 Therapeutic Radioisotopes Product Offered
12.8.3 Lantheus Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 Lantheus News
12.9 Spectrum Pharmaceuticals
12.9.1 Company Details
12.9.2 Therapeutic Radioisotopes Product Offered
12.9.3 Spectrum Pharmaceuticals Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 Spectrum Pharmaceuticals News
12.10 Progenics Pharmaceuticals
12.10.1 Company Details
12.10.2 Therapeutic Radioisotopes Product Offered
12.10.3 Progenics Pharmaceuticals Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2017-2019)
12.10.4 Main Business Overview
12.10.5 Progenics Pharmaceuticals News
12.11 International Isotopes
13 Research Findings and Conclusion
